Briganti S, Flori E, Bellei B, Picardo M. Modulation of PPAR? provides new insights in a stress induced premature senescence model. PLoS ONE. 2014;9:e104045 pubmed publisher

Voloshyna I, Hai O, Littlefield M, Carsons S, Reiss A. Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPAR? and adenosine. Eur J Pharmacol. 2013;698:299-309 pubmed publisher

Liu H, Wang S, Sun A, Huang D, Wang W, Zhang C, et al. Danhong inhibits oxidized low-density lipoprotein-induced immune maturation of dentritic cells via a peroxisome proliferator activated receptor ?-mediated pathway. J Pharmacol Sci. 2012;119:1-9 pubmed

Lee M, Kim D, Kim H, Kim H, Yang J, Ryu S, et al. Cell death is induced by ciglitazone, a peroxisome proliferator-activated receptor ? (PPAR?) agonist, independently of PPAR? in human glioma cells. Biochem Biophys Res Commun. 2012;417:552-7 pubmed publisher

Rogue A, Lambert C, Josse R, Antherieu S, Spire C, Claude N, et al. Comparative gene expression profiles induced by PPAR? and PPAR?/? agonists in human hepatocytes. PLoS ONE. 2011;6:e18816 pubmed publisher

Tsukahara T, Hanazawa S, Kobayashi T, Iwamoto Y, Murakami Murofushi K. Cyclic phosphatidic acid decreases proliferation and survival of colon cancer cells by inhibiting peroxisome proliferator-activated receptor ?. Prostaglandins Other Lipid Mediat. 2010;93:126-33 pubmed publisher